MAY 08, 2018 11:45 PM PDT

Increased Melanoma Risk in Men Associated With Daily Aspirin Intake

WRITTEN BY: Mauri Brueggeman

A new study published in the Journal of the American Academy of Dermatology found that men who take daily aspirin have a significantly increased risk of developing melanoma as compared to men who did not take aspirin daily.  Women taking daily aspirin did not have an increased risk.

Melanoma is a type of skin cancer that accounts for about 1% of all skin cancers; despite being a small percentage of all skin cancers, melanoma is the deadliest. Additionally, according to the American Cancer Society, the melanoma diagnosis rate has been increasing steadily over the past 30 years. 

The researches from Northwestern University studied the medical records of just under 200,000 patients ages 18-89 who had no prior history of melanoma.  Nearly 1200 patients were considered “aspirin exposed” having taken a daily dose of 81 to 325 mg per day for one year.  Patients were followed for 5 years and of those aspirin exposed patients, just under 2.2% had a subsequent diagnosis of melanoma within the 5 years of study.  Of the unexposed patient population, 0.86% were diagnosed with melanoma during that same time.

The study split the groups by gender to evaluate for additional information and found that men taking aspirin daily had almost two times the risk of melanoma than men who did not take aspirin daily.

This study does not advocate for men to discontinue taking aspirin daily, however.  Aspirin is useful for pain, decreasing cardiovascular risk, and has been previously found to reduce risk of other types of cancers like that of the colon or prostate.  The study authors did indicate that this information can be useful in monitoring and educating patients on appropriate use of sunscreen or alternative methods to reduce sun exposure. 

Some have suggested that the difference in gender risk found in this study may be due to decreased levels of protective enzymes in men, as compared to women.  These protective enzymes, like catalase, have been referenced in the literature as antioxidants and provide cellular protection against oxidative stress.

Sources: Journal of the American Academy of Dermatology, American Cancer Society, Nature Protocols,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
AUG 13, 2021
Drug Discovery & Development
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
AUG 13, 2021
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis. The stu ...
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
SEP 18, 2021
Genetics & Genomics
Cancer Genes Might Aim for the Immune System, Not Growth Promotion
SEP 18, 2021
Cancer Genes Might Aim for the Immune System, Not Growth Promotion
The DNA in our cells can accumulate damage over may years. Environmental influences like UV light or cigarette smoke may ...
OCT 01, 2021
Health & Medicine
Eppendorf Award 2022: Call for Entries
OCT 01, 2021
Eppendorf Award 2022: Call for Entries
Eppendorf Award 2022: Call for Entries The Eppendorf Award for Young European Investigators, endowed with 20,000 EUR, is ...
NOV 22, 2021
Cancer
A New Treatment Option for Patients with Cancer in the Eye
NOV 22, 2021
A New Treatment Option for Patients with Cancer in the Eye
Uveal melanoma (UM) is a rare malignancy characterized by the formation of cancer cells in the tissues of the eye. UM be ...
Loading Comments...